2012, Number S1
<< Back Next >>
Rev Mex Anest 2012; 35 (S1)
What happens with anesthetics drugs in the young obese patient?
Zaragoza-Saavedra JJM
Language: Spanish
References: 10
Page: 195-196
PDF size: 63.40 Kb.
Text Extraction
No abstract
REFERENCES
http://www.who.int/topics/obesity.
http://www.paho.org/spanish/ad/dpc/nc/obesity.
Casati A. Anesthesia in the obese patient: Pharmacokinetic considerations. J Clin Anesth 2005;17:134-145.
Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004;58:119-33.
Pai M. The origin of the “ideal” body weight equations. Ann Pharmacother 2000;34:1066-9.
Janmahasatian S. Quantification of lean bodyweight. Clin Pharmacokinet 2005;44:1051-1064.
Cortinez B. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anesth 2010;105:448-456.
Shibutani K. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 2005;95:377-83.
Ingrande J. Dose adjustment of anaesthesics in the morbidly obese. Br J Anaesth 2010;105:i16-i23.
Montoya T. Manejo anestésico en el paciente obeso mórbido sometido a cirugía bariátrica. Rev Mex Cir Endos 2008;9:188-193.
Full text